Patients undergoing coronary angiography often experience anxiety both before and during the procedure, often treated by the administration of anti-anxiety medications. A new analysis being presented at the American College of Cardiology (ACC) Middle East 2025 Together with 16^th Emirates Cardiac Society Conference found virtual reality (VR) effectively reduced anxiety during the procedure and had more stable vital signs than patients receiving standard care.

Foreign born immigrants to the United States have a lower risk of cardiovascular disease than their U.S.-born counterparts; however, that advantage diminishes the longer they live in the U.S., according to a study presented at the American College of Cardiology’s Middle East 2025 Together with 16th Emirates Cardiac Society Conference taking place October 3-5, 2025, in Dubai, UAE.

Findings aimed at tailoring treatment to patients’ specific anatomy

The National Institutes of Health’s National Institute on Drug Abuse (NIDA) has awarded $3.7 million to Indiana University researchers to investigate the complex relationship between ADHD medications and serious substance use problems among vulnerable youth and young adults. The study aims to fill critical gaps in understanding how ADHD medications impact the risk of serious substance use problems by analyzing nationwide healthcare data of over 3.3 million young people (ages 9-29) enrolled in Medicaid who received an ADHD diagnosis.

More than half of survivors of the Sudan Ebola virus still suffer serious health problems two years post-infection and the virus can persist in semen and breast milk for months after recovery, according to the first study examining the virus’s long-term effects.